Japanese Drug Makers Lag U.S. And Europeans In Drug Access Ranking
This article was originally published in PharmAsia News
Executive SummaryFor the first time, Japanese pharmaceutical companies were ranked by Access to Medicine Index, measuring companies' efforts to make drugs available to people in developing countries
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.